Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of MenABCWY versus MenB and MenACWY vaccines given together or alone in healthy adolescents and young adults
2017-005128-12Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of Meningococcal ABCYW vaccine, Multicomponent meningococcal B vaccine, meningococcal conjugate vaccine in meningococcal disease, sponsored by GSK. Started Mar 2018; status: completed.
02
Drugs
Meningococcal ABCYW vaccineMulticomponent meningococcal B vaccinemeningococcal conjugate vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on 2017-005128-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005128-12.